Picture of WuXi Biologics (Cayman) logo

2269 — WuXi Biologics (Cayman) News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapHigh Flyer

Brief: Wuxi Biologics Posts HY Net Profit Attributable Of RMB1,499.1 Mln

Aug 21 (Reuters) - WuXi Biologics (Cayman) Inc
 2269.HK :
    * HY NET PROFIT ATTRIBUTABLE RMB1,499.1 MILLION
    * RESOLVED NOT TO DECLARE ANY INTERIM DIVIDEND FOR SIX
MONTHS
ENDED JUNE 30,  2024

Further company coverage:  2269.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on WuXi Biologics (Cayman)

See all news